Skip to content

Meditron

Active Public limited companyfounded 1997active for 29 yearsBeekstraat 47, 9170 Sint-Gillis-WaasKBO/BCE: BE 0461.538.767

Lifetime

19 annual accounts with figures on one time axis, 28 filings since 1998
peak of €331,914 in 2011
€33,734▼ 39.0%
lowest -€63,218 in 2016
€22,383▼ 44.3%
peak of €610,410 in 2013
€433,685▲ 5.2%
€54,400▼ 24.3%
peak of 1 FTE in 2007
-not published
Board8 names since 2013
3 directors and 2 others
Documentsfilings and deeds
26-02-202663 days before the deadline
2025micro format
Gross margin from €55,325 to €33,734Result from €40,158 to €22,383Dividend €1,000Debts from €71,818 to €54,400Cash from €73,000 to €42,050

Key points

from the 2025 annual accounts

Equity

€433,685 ▲ 5.2%

Meditron has made a profit without a break since 2017.

Filings

28 annual accounts since 1998
deadline200020102020

The last five annual accounts were filed 54 to 65 days before the end of the period.

Position in the sector

€433,685

More equity than 90% of companies in wholesale trade. Sector median €57,961 · 15,503 companies.

Checked score

Bankruptcy probability within 12 months

Financial strength

Score breakdown

Comparable companies, two years later

In July 2024, 14,774 companies had the same profile as Meditron has now. Each dot stands for 37 companies, two years later.

96.1%
were still trading
3.5%
stopped another way
0.2%
went bankrupt
  • Small
  • 20 years or older
  • solvency 30% or more
  • a profit under 5% of the balance sheet

Another 0.1% stopped without a precise date, possibly only after those two years.

Test of the method

The method was tested on the 497,962 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 0.9%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.8%
9 2.9% 3.1%
10 5.6% 6.1%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 14,774 companies, not a prediction for Meditron. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit verdict

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Board and ownership

Managing director
Director
Director
  • deed of 30-09-2014
  • deed of 30-09-2014
Board & ownership

Recent changes

Registered in the Peppol Directory Reachable for e-invoices through 0208:0461538767
3 directors appointed (managing director), and · General meeting of 23-02-2022 · Gazette deed
Capital decrease of €100,000 to €232,000 The capital fell from €332,000 to €232,000 · General meeting of 03-04-2019 · Gazette deed
3 directors appointed (managing director), and · General meeting of 24-02-2016 · Gazette deed
All 40 events

Comparable companies

same main activity, similar in size and age
Company
Meditron Sint-Gillis-Waas €488,085 €33,734 88.9% -
ECOPHARMASUPPLY DISTRIBUTION Estaimpuis €620,829 €37,492 65.0% -
PATRIMOL Stekene €619,408 €29,592 19.3% -
THE FOXY'S Laarne €407,254 €61,968 46.0% -
IMMO VITA Braine-l'Alleud €609,667 €26,076 -5.2% -
MEDICAL CARE SYSTEMS Gingelom €501,640 €34,697 93.1% -
ADOCS Machelen (Brab.) €717,403 €45,936 66.4% -

These companies have the same main activity as Meditron: wholesale of pharmaceutical and medical goods (NACE 46460). They are comparable in size and age: total assets between €407,000 and €717,000, founded between 1988 and 2001.

Official details

Source: KBO
Status
Active since 01-10-1997Normal situation
Activity
Wholesale of pharmaceutical and medical goodsNACE 46460and 2 others
Financial year end
30 September
Peppol
Reachable since 10-02-2026
Company details

Annual accounts to 30-09-2025

≈ €170,000estimated
€488,085▲ 0.8%
Filing
Filed on 26-02-2026, 63 days before the end of the filing period
Financials

Insights on Meditron

Meditron files the micro format. That format states no turnover. The gross margin fell from €182,071 in 2007 to €33,734 in 2025.

In March 2022, the Official Gazette published the appointment of as managing director.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about Meditron

What is the company number of Meditron?
The company number of Meditron is 0461.538.767. The VAT number is the same number with BE in front: BE 0461.538.767.
Where is Meditron based?
The registered office is at Beekstraat 47, 9170 Sint-Gillis-Waas.Company details
What does Meditron do?
According to the KBO register, the main activity is wholesale of pharmaceutical and medical goods (NACE 46460).
What is the legal form of Meditron?
Meditron is a public limited company (NV).
When was Meditron founded?
Meditron was founded on 01-10-1997.
Is Meditron still active?
Yes, Meditron is an active enterprise in the KBO register.
What is the turnover of Meditron?
The turnover in financial year 2025 is ≈ €170,000. This figure is estimated from the gross margin of €33,734 and 34 comparable companies (NACE 464). It probably lies between €110,000 and €350,000.Financials
Is Meditron profitable?
In financial year 2025, Meditron made a profit of €22,383.
Where can I find the annual accounts of Meditron?
Meditron filed 28 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of Meditron due?
Meditron must file the annual accounts for financial year 2026 by 30-04-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.